Save the date to be part of the future of immune therapy research.
About the event
On 18-19 May 2026, the British Society for Immunology (BSI) Immune Therapies Summit will return to Hinxton Hall, Cambridge. This unique event brings together sector leaders from industry, academia and clinical spheres to discuss novel approaches and future challenges in immune therapies research. With internationally renowned speakers and an engaging and interactive programme, this event is an exceptional opportunity to build your cross-sector networks, learn more about current insights and trends in immune therapy development and be part of the conversation to drive forward the next iteration of immunotherapy research for patient benefit.
Keynote speaker: Shannon Turley, who is Vice President of Research and Co-Head of Research Biology at Amgen, overseeing the Oncology and Immunology therapeutic areas.
Plenary topics and speakers:
- Approaches to a Cure: John Isaacs (Newcastle University), Rowann Bowcutt (UCB)
- AI in Drug Discovery and Development: James Zou (Stanford), Emily Corse (NOETIK)
- Mucosal Targeting: Clare Lloyd (Imperial College London), Deborah O'Neil (NovaBiotics)
- Learning from Failure as well as success: Jeff Ravetch (The Rockerfeller University), Mark Peakman (Sanofi)
Workshops:
- Developing products for Rare Diseases
- Applied AI - in practice
- Mitigating risks of immunotherapies
- Barriers to Treg therapy
- Advanced trial designs
- Bispecifics: successes and challenges
- Genetically engineered advance therapy
- Identifying novel targets for therapy
Who should attend?
The BSI Immune Therapies Summit is aimed at senior leaders from industrial, academic and clinical research settings who are passionate about accelerating immune therapy development and building their cross-sector networks in this field.
Why should you attend?
- Unparalleled and varied networking opportunities with sector leaders from industry, academia and health fields
- Cutting-edge talks and discussions from leading international experts
- Opportunity to take part in holistic, cross-disease discussions on the latest developments across the spectrum of immunotherapy research
- Take part in dynamic focus sessions on how we can accelerate novel approaches to immune therapies research
Sponsorship and exhibition opportunities
There are a number of ways that companies can engage and participate in the BSI Immune Therapies Summit. To learn more about the opportunities available, please contact Becky Dempsey, Events and Corporate Engagement Manager, at b.dempsey@immunology.org.